$Bristol-Myers Squibb (BMY.US)$ FDA Approves Augtyro (repotr...
⇨ next-gen. Tyrosine Kinase Inhibitor (TKI) ⚛️
⇨ the only FDA-approved treatment for NTRK-positive tumors 👏
⇨ accelerated approval (sNDA) marks its 2nd indication in the US
⇨ the only FDA-approved treatment for NTRK-positive tumors 👏
⇨ accelerated approval (sNDA) marks its 2nd indication in the US
⇨ based on Ph1/2 TRIDENT-1 trial 🧫
» effective in both TKI-naïve & TKI-pretreated patients across solid tumors
» showed significant response rates
» effective in both TKI-naïve & TKI-pretreated patients across solid tumors
» showed significant response rates
![$Bristol-Myers Squibb (BMY.US)$ FDA Approves Augtyro (repotrectinib) 🎉 ⇨ next-gen. Tyrosine Kinase Inhibitor (TKI) ⚛️ ⇨ the only FDA-approved treatment for NT...](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240614/f94cae907d0e441eb46e045b27344f65.png/big?area=100&is_public=true)
![$Bristol-Myers Squibb (BMY.US)$ FDA Approves Augtyro (repotrectinib) 🎉 ⇨ next-gen. Tyrosine Kinase Inhibitor (TKI) ⚛️ ⇨ the only FDA-approved treatment for NT...](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240614/fdece2eca2e8415fa1bb20c516b3e178.png/big?area=100&is_public=true)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment